Sobrevida de pacientes con cáncer de mama Her2 positivo tratadas en el Hospital de Solca Loja

Breast cancer HER2 positive (BRCA HER2 +) represents 20 to 30% of breast cancers, until before biological therapies was the most aggressive, with a 5-year survival of 74%. This is why arises the need for the current research whose main objective was to determine the 5-year survival in patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Macas Cabrera, Brayan Edison (author)
Format: bachelorThesis
Idioma:spa
Publicat: 2019
Matèries:
Accés en línia:http://dspace.unl.edu.ec/jspui/handle/123456789/22031
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!